Lars Prestegarden, MD, PhD, is the co-founder and Chief Executive Officer (CEO) of Cytovation. Dr Prestegarden brings over 20 years of experience in cancer research. Before founding Cytovation, he conducted research at the University of California, San Francisco (UCSF) and was a Fulbright Fellow at Harvard Medical School and Brigham and Women’s Hospital. Following his fellowship, he held the position of Associate Professor of Medicine at the University of Bergen in Norway.